Gerresheimer reports strong earnings and sales growth
(ots) -
Group revenues in the third quarter up by 9.5% to EUR 259.4m
(excluding Technical Plastic Systems)
Marked rise in operating margin (Adjusted EBITDA margin) from
17.3% to 20.5%
Adjusted earnings per share more than doubled from EUR 0.20 to
EUR 0.52
Net financial debt reduced by EUR 74.1m
Gerresheimer AG, one of the leading worldwide suppliers to
the pharma and healthcare industry, is continuing its growth
course in the financial year 2010. "Our business is developing
well. We continue to focus on the field of pharma and
healthcare. Doing so we are achieving solid and profitable
growth," says Uwe Röhrhoff, CEO of Gerresheimer AG.
In the third quarter of 2010, Gerresheimer further strengthened
its revenues. In the period from June to August 2010 the
company increased its revenues (excluding the Technical Plastic
Systems business which has been sold) by 9.5% to EUR 259.4m (prior
year EUR 236.9m). At constant exchange rates, revenues grew by
5.8% in the third quarter. In the first three quarters,
Gerresheimer achieved revenue growth of 4.4% at constant exchange
rates to EUR 753.0m (prior year excluding Technical Plastic
Systems: EUR 714.9m). The main growth generators in the pharma
business were insulin pens, asthma inhalers and prefillable
syringes. Additionally, a resurgence of demand for cosmetics
packaging and economic recovery in the laboratory glassware
segment had a positive impact on the business trend.
Gerresheimer also achieved a further rise in earnings. For the
third quarter of the financial year the company reports operating
earnings (Adjusted EBITDA) of EUR 53.3m, 28.1% up on the
prior-year period (third quarter 2009 excluding Technical Plastic
Systems: EUR 41.6m). In the third quarter of 2010 the operating
margin (Adjusted EBITDA margin) improved by 3.2 percentage points
in comparison with the prior year to 20.5% (first three quarters
2010: 19.6%). Adjusted earnings per share improved substantially
from EUR 0.20 to EUR 0.52. As a result of the positive business
trend, Gerresheimer was able to reduce net financial debt by EUR
74.1m to EUR 356.6m (prior year: EUR 430.7m)
"The combination of organically generated growth and
targeted acquisitions forms the foundation for the further
successful development of our company. We concentrate on profitable
markets and continuously expand our position as a market leader
globally. Our presence in the emerging markets is therefore more
important than ever," says Röhrhoff.
Outlook
For the current financial year 2010, Gerresheimer continues
to expect revenue growth of 3% to 4% at constant exchange
rates, excluding Technical Plastic Systems. This is equivalent to
nominal sales growth of 5% to 6%. The company also stands by its
forecast EBITDA margin of 19.5% to 20%. In 2010 the company expects
to invest a total of EUR 75-80m.
About Gerresheimer
Gerresheimer is an internationally leading manufacturer of
high- quality specialty products made of glass and plastic for the
global pharma & healthcare industry. Our wide product spectrum
ranges from pharmaceutical vials to complex drug delivery
systems, such as syringe systems, insulin pens and inhalers, for
safe dosage and application. Together with our partners we develop
solutions which set standards and have role-model status throughout
their respective business sectors.
Our Group of companies achieves in Europe, North and South
America and Asia sales of about EUR 1 billion and employs
around 9,500 people. Through top-class technologies, convincing
innovations and targeted investments we are systematically
expanding our strong market position.
The full version of the interim report can be found under:
http://www.gerresheimer.com/en/investor-relations/reports.html
Group Key Figures (IFRS; Financial Year end November 30)
|in EUR million |Q3 |Q3 |( % |FY |
|2010 |2009 | |2009 |
|Revenues |259.4|242.6|+6.9 |1,000.|
|Group revenues excluding | | |+9.5 |2 |
|Technical Plastics1 |259.4|236.9|+5.85|970.8 |
|Adjusted EBITDA2 |53.3 |42.0 |+26.9|185.9 |
|in % of revenues |20.5 |17.3 | |18.6 |
|Adjusted EBITDA2 excluding |53.3 |41.6 |+28.1|186.2 |
|Technical Plastics1 | | | | |
|in % of revenues |20.5 |17.6 | |19.2 |
|Profit from operations |26.3 |12.9 |>100 |60.5 |
|(EBIT) | | | | |
|Net income |14.1 |-4.0 |>100 |7.0 |
|Adjusted net income3 |18.4 |7.9 |>100 |45.2 |
|Earnings per share in EUR |0.41 |-0.11|>100 |0.18 |
|Adjusted earnings per |0.52 |0.20 |>100 |1.34 |
|share4 in EUR | | | | |
|Equity ratio in % |37.7 |34.7 | |35.8 |
|Net Financial Debt |356.6|430.7|-17.2|373.3 |
|Capital expenditure |13.5 |19.1 |-29.3|86.4 |
1 The Technical Plastic Systems segment was sold with effect
from July 1, 2009.
2 Adjusted EBITDA: Earnings before income taxes, financial
result, amortization of fair value adjustments, extraordinary
depreciation, depreciation and amortization, restructuring
expenses and one-off income and expenses.
3 Adjusted net income: Consolidated profit before non-cash
amortization of fair value adjustments, special effects from
restructuring
expenses, extraordinary depreciation, the balance of one-off
income and expenses (including significant non-cash expenses) and
the related tax effects.
4 Adjusted net income after minorities divided by 31.4m
shares.
5 Revenue growth rate at constant exchange rates.
Group Key Figures (IFRS; Financial Year end November 30)
|in EUR million |Q1-Q3 |Q1-Q3 |( % |FY |
| |2010 |2009 | |2009 |
|Revenues |753.0 |744.3 |+1.2 |1,000.|
|Group revenues excluding |753.0 |714.9 |+5.3 |2 |
|Technical Plastics1 | | |+4.45 |970.8 |
|Adjusted EBITDA2 |147.9 |127.8 |+15.7 |185.9 |
|in % of revenues |19.6 |17.2 | |18.6 |
|Adjusted EBITDA2 excluding|147.9 |128.1 |+15.5 |186.2 |
| | | | | |
|Technical Plastics1 |19.6 |17.9 | |19.2 |
|in % of revenues | | | | |
|Profit from operations |63.4 |33.9 |+87.0 |60.5 |
|(EBIT) | | | | |
|Net income |27.7 |-4.2 |>100 |7.0 |
|Adjusted net income3 |43.6 |28.6 |+52.4 |45.2 |
|Earnings per share in EUR |0.85 |-0.15 |>100 |0.18 |
|Adjusted earnings per |1.33 |0.83 |+60.2 |1.34 |
|share4 in EUR | | | | |
|Equity ratio in % |37.7 |34.7 | |35.8 |
|Net Financial Debt |356.6 |430.7 |-17.2 |373.3 | |
Capital expenditure |43.0 |50.3 |-14.5 |86.4 |
1 The Technical Plastic Systems segment was sold with effect
from July 1, 2009.
2 Adjusted EBITDA: Earnings before income taxes, financial
result, amortization of fair value adjustments, extraordinary
depreciation, depreciation and amortization, restructuring
expenses and one-off income and expenses.
3 Adjusted net income: Consolidated profit before non-cash
amortization of fair value adjustments, special effects from
restructuring
expenses, extraordinary depreciation, the balance of one-off
income and expenses (including significant non-cash expenses) and
the related tax effects.
4 Adjusted net income after minorities divided by 31.4m
shares.
5 Revenue growth rate at constant exchange rates.
Media contact
Investor Relations contact Jens Kürten
Director Corporate Communication & Marketing
Telephone +49 211 6181-250
Telefax +49 211 6181-241
E-Mail j.kuerten(at)gerresheimer.com
Anke Linnartz
Director Investor Relations
Telephone +49 211 6181-314
Telefax +49 211 6181-121
E-Mail a.linnartz(at)gerresheimer.com
Themen in diesem Fachartikel:
Unternehmensinformation / Kurzprofil:
Capital Market Da" alt="EANS-Adhoc: ANDRITZ bekräftigt langfristige Unternehmensziele anlässlich desDatum: 06.10.2010 - 07:45 Uhr
Sprache: Deutsch
News-ID 270034
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner:
Stadt:
Düsseldorf
Telefon:
Kategorie:
Finanzen
Anmerkungen:
Dieser Fachartikel wurde bisher 147 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Gerresheimer reports strong earnings and sales growth"
steht unter der journalistisch-redaktionellen Verantwortung von
Gerresheimer AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).